Related Experiment Video
Updated: Sep 10, 2025
07:55
Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.1K
Pancreatic Cancer Immunotherapy: A Team-Based Approach
Krushangi Patel1, Percy Lee2, Julius Weng2
1City of Hope Department of Medical Oncology & Therapeutics Research, City of Hope Comprehensive Cancer Center Long Beach, Long Beach, CA, USA. KruPatel@coh.org.
Cancer Treatment and Research
|August 23, 2025
Summary
Immunotherapy shows promise in cancer treatment but faces challenges in pancreatic cancer. Overcoming the tumor microenvironment is key to developing effective immunotherapies for pancreatic cancer patients.
Area of Science:
- Oncology
- Immunology
- Cancer Research
Background:
- Immunotherapy offers effective cancer treatment with manageable toxicity.
- Pancreatic cancer has shown limited response to current immunotherapeutic strategies.
- The tumor microenvironment presents a significant barrier to immunotherapy efficacy in pancreatic cancer.
Purpose of the Study:
- To explore the challenges limiting immunotherapy effectiveness in pancreatic cancer.
- To understand the role of the tumor microenvironment in pancreatic cancer progression and treatment resistance.
- To identify strategies for optimizing immunotherapeutic approaches in pancreatic cancer.
Main Methods:
- Review of current literature on cancer immunotherapy.
- Analysis of the pancreatic tumor microenvironment's impact on immune responses.
- Exploration of therapeutic development strategies for pancreatic cancer.
Main Results:
- Immunotherapy efficacy is often limited in pancreatic cancer.
- The pancreatic tumor microenvironment is a major obstacle to successful immunotherapy.
- A comprehensive, team-based approach is needed to understand and overcome these challenges.
Conclusions:
- Addressing the hostile tumor microenvironment is crucial for advancing pancreatic cancer immunotherapy.
- Optimizing treatment strategies requires a deep understanding of pancreatic cancer biology and its microenvironment.
- Developing combination therapies may lead to long-standing efficacy for pancreatic cancer patients.
Keywords:
Cytotoxic T-lymphocyte-associated protein 4 (CTLA-4)Immune checkpoint blockade (ICB)Overall response rate (ORR)Overall survival (OS)Pancreatic ductal adenocarcinoma (PDAC)Programmed cell death protein 1 (PD1)Progression-free survival (PFS)Tumor microenvironment (TME)Tumor-infiltrating lymphocyte therapy (TILs)More Related Videos
Related Concept Videos
01:27Tumor Immunotherapy
660
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
660
01:30Cancer Vaccines
509
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
509
01:29Chronic Pancreatitis II: Collaborative Care
128
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
Assessment:
128
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K